CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on developing NeuroProtect, a natural compound aimed at healing damaged neurons in neurodegenerative diseases like Amyotrophic Lateral Sclerosis. By targeting ALS, the project seeks to expedite clinical approval and market entry, potentially reducing the economic burden of the disease.
Over 10M Europeans suffer from neurodegenerative diseases such as Alzheimer’s Disease (AD), Parkinson’s Disease (PD) and Amyotrophic Lateral Sclerosis (ALS).
Whilst there are many drugs that treat symptoms of these diseases, there are no therapies that can reverse or cure them.Our novel compound NeuroProtect has the potential to be a game changer by healing damaged neurons.
NeuroProtect is a natural herb-derived compound with remarkable neuroprotective, neuro-rescuing, anti-apoptotic, and axon-o…
SUNREGEN HEALTHCARE AG
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
